Home δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
Article
Licensed
Unlicensed Requires Authentication

δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients

  • Chaima Abdelhafidh Sahli , Amina Bibi EMAIL logo , Faida Ouali , Hajer Siala , Sondess Hadj Fredj , Rym Othmani , Fekria Ouenniche , Mondher Cheour , Zohra Fitouri , Saida Ben Becher and Taieb Messaoud
Published/Copyright: April 20, 2012

Abstract

Background: β-Thalassemia is the most common disease among hemoglobinopathies in North African and Arab populations. In the present study we report the first description of the β-Knossos codon27 (G→T) (βKnossos) allele in cis with the δ059 (-A) mutation in thalassemia intermedia patients in Tunisia and Libya.

Methods: This identification was carried out by sequencing analysis of the whole coding regions of the δ- and β-globin genes.

Results: We noted that heterozygous inheritance of the βKnossos mutation results in a mild β-thalassemia phenotype with a low level of HbA2 while homozygous leads to intermediate β-thalassemia with an atypical high performance liquid chromatogram showing a complete absence of HbA2 and HbF. Compound heterozygosity of the βKnossos with β0codon39 (C→T) is identified in a Tunisian proband for the first time and gives rise to a mild phenotype. In both families, the δ0codon59 (-A) and the βKnossos alleles were found to be associated with a single Mediterranean β-haplotype I similar to that observed in previous reports from Algeria, Egypt, Cyprus, and Turkey.

Conclusions: The chromosome supporting the βKnossos and the δ0codon59 (-A) alleles seems to be of a single Mediterranean origin. Premarital screening studies in families in which only one of the parents has typical aspects of β-thalassemia trait and the other has a normal HbA2 level associated with abnormal red cell indices becomes a necessity to avoid missing thalassemia carriers.


Corresponding author: Amina Bibi, MD, Biochemistry Laboratory, Children’s Hospital, Bab Saadoun Square, Tunis, Tunisia Phone: +216 98 414607, Fax: +216 71 566463

Received: 2012-1-12
Accepted: 2012-3-19
Published Online: 2012-04-20
Published in Print: 2012-10-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorials
  4. Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
  5. Laboratory networking and sample quality: a still relevant issue for patient safety
  6. Reviews
  7. DNA methylation biomarkers and their utility for solid cancer diagnostics
  8. DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
  9. Global DNA hypomethylation in cancer: review of validated methods and clinical significance
  10. Genetics and Molecular Diagnostics
  11. δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
  12. Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
  13. General Clinical Chemistry and Laboratory Medicine
  14. Effects of sample transportation on commonly requested laboratory tests
  15. Long-term (in)stability of folate and vitamin B12 in human serum
  16. Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
  17. First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
  18. Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
  19. Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
  20. Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
  21. Cancer Diagnostics
  22. Increased concentrations of growth factors and activation of the EGFR system in breast cancer
  23. Infectious Diseases
  24. Incidence and significance of elevated lactate in the identification of critically ill patients
  25. Cardiovascular Diseases
  26. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
  27. Diabetes
  28. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
  29. Letters to the Editor
  30. Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
  31. Application of quality specification based on biological variation in planning quality control strategy
  32. Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
  33. Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
  34. Assay-specific pitfalls of catecholamine HPLC assays
  35. Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
  36. Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
  37. Congress Abstracts
  38. Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
  39. Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
Downloaded on 13.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0102/html
Scroll to top button